Obiltoxaximab Solution for injection

March 22, 2017

Obiltoxaximab Solution for injection

What is this medicine?

Obiltoxaximab is used to help prevent or to help treat anthrax.

How should I use this medicine?

This medicine is for infusion into a vein. It is given by a health care professional in a hospital or clinic setting.

Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for selected conditions, precautions do apply.

What side effects may I notice from receiving this medicine?

Side effects that you should report to your doctor or health care professional as soon as possible:

  • allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue

  • breathing problems

  • chest pain or tightness

  • dizziness

Side effects that usually do not require medical attention (report these to your doctor or health care professional if they continue or are bothersome):

  • congestion

  • cough

  • headache

  • pain, redness, or irritation at site where injected

What may interact with this medicine?

Interactions are not expected.

What if I miss a dose?

This does not apply; this medicine is not for regular use.

Where should I keep my medicine?

This drug is given in a hospital or clinic and will not be stored at home.

What should I tell my health care provider before I take this medicine?

They need to know if you have any of these conditions:

  • an unusual or allergic reaction to obiltoxaximab, other medicines, foods, dyes, or preservatives

  • pregnant or trying to get pregnant

  • breast-feeding

What should I watch for while using this medicine?

Tell your doctor or healthcare professional if your symptoms do not start to get better or if they get worse.

This medicine can cause allergic reactions. To reduce your risk you may need to take medicine before treatment with this medicine. Take your medicine as directed.

Your condition will be monitored carefully while you are receiving this medicine.

Updated:  

March 22, 2017